|
The Affordable Care Act (ACA) health insurance marketplaces are poised to break enrollment records for the third consecutive year, with over nineteen million Americans signing up for Obamacare plans. HealthCare.gov saw its largest day ever on December 15, with 745,000 enrollments, and the current total includes individuals from both state-based and federal marketplaces.
|
Amidst challenges accessing newer weight loss drugs like Zepbound and Wegovy, older medications in the category, such as Ozempic and Wegovy, are experiencing a resurgence. Insurance hurdles and shortages often impede access to the newer drugs, prompting patients and doctors to turn to older alternatives like bupropion, metformin, and phentermine, which can be more affordable and come in pill form, avoiding the need for injections .
|
A controversial Census Bureau proposal to change disability estimation methods by shifting from yes-or-no questions to rating difficulty levels has sparked concerns among advocates, potentially reducing the estimated share of the U.S. population with disabilities by about 40%. Critics fear it could impact access to resources and legal protections for disabled individuals.
|
The U.S. is currently experiencing a "sharp increase" in flu levels, particularly in the southern regions, and COVID-19 cases are also on the rise nationally, according to Dr. Mandy Cohen, the director of the Centers for Disease Control and Prevention. Although cases of respiratory syncytial virus (RSV) have peaked earlier this season, Cohen stated that the U.S. is not yet near the peak for flu or COVID-19, emphasizing the importance of updated vaccinations to address emerging variants like JN.1.
|
The US Food and Drug Administration (FDA) has approved the AutoGenomics AvertD test, a genetic tool designed to assess the risk of developing opioid use disorder (OUD). The test analyzes 15 genetic markers related to the brain's reward pathways and addiction. While some experts are skeptical about its use in clinical practice, the FDA sees it as a step forward in efforts to prevent new cases of OUD and support treatment, aiming to decrease the misuse of opioid analgesics.
|
|